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Abstract LMNA gene encodes for nuclear intermediate fila-
ment proteins lamin A/C. Mutations in this gene lead to a
spectrum of genetic disorders, collectively referred to as
laminopathies. Lamin A/C are widely expressed in most dif-
ferentiated somatic cells but not in early embryos and some
undifferentiated cells. To investigate the role of lamin A/C in
cell phenotype maintenance and differentiation, which could
be a determinant of the pathogenesis of laminopathies, we
examined the role played by exogenous lamin A and its mu-
tants in differentiated cell lines (HeLa, NHDF) and less-
differentiated HEK 293 cells. We introduced exogenous
wild-type and mutated (H222P, L263P, E358K D446V, and
Δ50) lamin A into different cell types and analyzed proteins’
impact on proliferation, protein mobility, and endogenous nu-
clear envelope protein distribution. The mutants give rise to a
broad spectrum of nuclear phenotypes and relocate lamin C.
The mutations Δ50 and D446Venhance proliferation in com-
parison to wild-type lamin A and control cells, but no changes
in exogenous protein mobility measured by FRAP were ob-
served. Interestingly, although transcripts for lamins A and C
are at similar level in HEK 293 cells, only lamin C protein is
detected in western blots. Also, exogenous lamin A and its
mutants, when expressed in HEK 293 cells underwent
posttranscriptional processing. Overall, our results provide
new insight into the maintenance of lamin A in less-
differentiated cells. Embryonic cells are very sensitive to
lamin A imbalance, and its upregulation disturbs lamin C,
which may influence gene expression and many regulatory
pathways.
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Introduction
Mutations in genes encoding for lamins and lamina-associated
proteins, such as LEM domain proteins (LAP2, emerin, and
MAN1), cause human genetic disorders that are collectively
referred to as laminopathies or envelopathies. This heteroge-
neous group comprises diseases of different clinical course,
severity, and molecular background. The best-known
laminopathy phenotypes are based on mutations in the
LMNA gene (autosomal), which encodes for lamins A and
C, and the EMD gene (X-linked), which encodes for emerin
(Worman and Bonne 2007; Zaremba-Czogalla et al. 2011).
Tissues of mesenchymal origin are affected in these disor-
ders and the phenotypic subgroups include muscular, periph-
eral neurogenic, lipodystrophy, and premature aging syn-
dromes (Worman and Bonne 2007). The most common dis-
ease phenotypes are the Bclassical,^ muscle-related
laminopathies, such as Emery-Dreifuss muscular dystrophy
type 2 (EDMD2) (Bonne et al. 1999), with symptoms such
as muscle contractures, generalized muscle atrophy, rigidity of
the spine, cardiac insufficiency, and ventricular arrhythmia.
One of the most severe genetic disorders from this group is
the very rare Hutchison-Gilford progeria syndrome (HGPS).
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Its typical cause is a 1824C>T mutation in the LMNA gene,
resulting in the activation of a cryptic splicing site in exon 11
of the primary transcript (Eriksson et al. 2003). This leads to
the synthesis of a lamin A deletion mutant protein (lamin A
Δ50, progerin) lacking 50 amino acids. The mutation prevents
the last step of prelamin A posttranslational modification,
meaning the protein remains permanently farnesylated.
Various disease phenotypes arise due to the modulation of
different intracellular processes by lamin A/C, including intra-
cellular signaling, regulation of transcription, maintenance of
nuclear shape, chromatin organization, and nuclear pore spac-
ing (Wiesel et al. 2008; Shimi et al. 2010; Dubinska-Magiera
et al. 2013). Thus, mutations in LMNA gene, depending on
their location and type, may disturb different functions of
lamin A/C and affect various processes. The interactions of
lamin A with LAP2α affect on the pRb signaling pathway,
which is involved in proliferation and regeneration, so there
is a high probability that a major mechanism in many of the
diseases is this pathway (Markiewicz et al. 2002; Pekovic
et al. 2007; Cohen et al. 2013).
Hundreds of mutations in the LMNA gene have been de-
scribed in patients. The related clinical courses have various
onsets, phenotypes, and severities. The mutations can be seen
in the Universal Mutation Database (http://www.umd.be), the
Human Intermediate Filament Database (http://www.interfil.
org), and the Leiden Open Variation Database (http://www.
dmd.nl). Some mutations, especially the first that had been
identified, have been thoroughly described and analyzed
using various model systems, such as patients’ fibroblasts
and myoblasts, cells transfected with constructs encoding for
mutated lamin A, transgenic animals, and cells obtained from
them. Each model system offers a number of possibilities to
dissect the various molecular mechanisms that give rise to the
phenotype associated with particular mutations. The limiting
factors on such studies are the restricted lifetime and
availability of the primary cells, especially for non-skin cells.
Analyses of skin fibroblasts revealed abnormalities such as
honeycomb and foci-forming expression patterns of lamin A
and nuclear blebbing and lobulations that disturb other nuclear
envelope (NE) proteins (Vigouroux et al. 2001; Favreau 2003;
Caux et al. 2003; Muchir et al. 2003). There are also a few
mouse models with LMNA deletion variants (Azibani et al.
2014) and lamin A mutations: ΔK32 (Bertrand et al. 2012),
H222P (Arimura et al. 2005), and N195K (Mounkes et al.
2005). Although a considerable amount of data was gathered
using these models, the disease phenotypes inmice differ from
those seen in humans.
Transfection of cell lines or primary cells allows the deri-
vation of the broadest screening and equal genetic background
for the comparison of mutants. Mouse embryonic fibroblasts
obtained from LMNA−/− mice transfected with lamin A vari-
ants clearly showed that some mutants tend to aggregate and
that emerin localization can be disturbed by specific mutations
(Raharjo et al. 2001; Holt et al. 2003). The impact of exoge-
nous lamin Amutants on cell phenotype was also investigated
in the cell lines C2C12 (Ostlund et al. 2001; Scharner et al.
2011), H9C2 and COS7 (Sylvius et al. 2008), CHO (Broers
2004), and in HeLa cells (Hübner et al. 2006; Manju et al.
2006), neonatal rat cardiomyocytes (Arimura et al. 2013), hu-
man mesenchymal stem cells (Malashicheva et al. 2015), and
human embryonic kidney 293 (HEK 293) cells (Tan et al.
2015; Liu et al. 2016). It was shown that lamin A mutants
diminish proliferation capacity (colony formation) and en-
hance the differentiation ability of transduced mesenchymal
stem cells (Malashicheva et al. 2015). Lamin A and its mu-
tants R48P, R249W, I373V, and I497_E536del showed a ten-
dency to aggregate in HEK 293 cells transfected with con-
structs encoding these proteins (Tan et al. 2015). The in-
creased mobility of the lamin A mutant R386K in a nucleo-
plasmic location was observed in bleaching experiments in
CHO cells (Broers et al. 2005). Recent studies demonstrated
that some mutations may lead to aggregation of lamins, thus
contributing to the disease phenotype (Alastalo et al. 2015;
West et al. 2016). Systemic screening of pathological lamin
A interaction was performed using yeast two-hybrid system
and partially verified by pull-down analyses, using 89 lamin A
mutations in U2OS cell line. This study confirmed the role of
Ig fold in interactions and confirmed the tissue-specific loss of
interaction as a main molecular background of the disease
phenotype (Dittmer et al. 2014).
In somatic tissues, the LMNA gene encodes for lamins A
and C, due to alternative splicing. Although they share many
functions, they have different expression patterns, regulatory
mechanisms, or assembly properties in different tissues (Al-
Saaidi and Bross 2015). The targeting of lamin C and some
other proteins (e.g., emerin) to the NE depends on lamin A
localization (Pugh et al. 1997; Vaughan et al. 2001), but it is
not clear how lamin mutations influence this process. Low-
level expression of mutant proteins did not influence lamin C
distribution in C2C12 cells (Scharner et al. 2011), but in COS-
7 cells, lamin C was slightly diminished in the nuclear rim due
to the presence of some lamin Amutants (Motsch et al. 2005).
Studies investigating different expression levels and cell
types were generally performed using antibodies recognizing
both lamins A and C, so it was not possible to clarify if lamin
C distribution was affected by lamin A mutations (Ostlund
et al. 2001; Vigouroux et al. 2001; Muchir et al. 2004).
Therefore, it is not clear whether lamin C can maintain its
function in the presence of lamin A mutant protein or indeed
compensate for the loss of lamin A function.
Our study focuses on two previously uncharacterized mu-
tations in the LMNA gene: L263P and D446V (Fig. 1, Table 1
for references). They had been discovered in Polish patients
with EDMD2. We also used three other mutations with differ-
ent molecular properties: H222P, E358K, and Δ50 (Fig. 1,
Table 1). Reports on L263P and D446V were published, but
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they have yet to be studied in tissue culture or animal model
systems. Patients bearing such LMNA gene mutations show
phenotypes corresponding to muscle-related laminopathies
(see Table 1).
There are practical limitations on the availability of patient
cells, so we conducted our studies on a tissue culture model
system that used both transient transfection and stable cell
lines. Three cell lines were used: normal human dermal fibro-
blast (NHDF), HeLa, and HEK 293. Most of the experiments
were performed on HEK 293 cells as it is the best model for
transient transfection studies due to the possibility of achiev-
ing high transfection efficiency. HEK 293 cells are usually
neglected in such studies, which typically focus on differenti-
ated cells with a high level of lamin proteins. Lamin A/C
depletion was shown to affect embryonic cell differentiation
(Sehgal et al. 2013), but the influence of dominant mutations
was not previously investigated in this context. Lamins A and
C are also critical for muscle cell differentiation (Frock et al.
2006). Since they affect intracellular signaling, understanding
the effect of mutated lamin A expression on cells that are not
fully differentiated may help to understand its function during
development.
In this paper, we demonstrate the subcellular distribution of
lamin A mutants and the effect of particular mutations on the
distribution and expression of endogenous NE proteins. We
also report on analyses of the proliferation of cells bearing a
particular mutation and on the mobility of mutated lamin A
proteins. Additionally, we proposed a mechanism for lamin A
removal in HEK 293 cells.
Materials and methods
Constructs and directed mutagenesis
Professor C.J. Hutchison’s lab supplied the N-terminal fusion
protein prelamin A in plasmid pEGFP-C1 (Clonetech).
Mutations were introduced via site-directed mutagenesis
using the following primer pairs for PCR:








All constructs were verified via sequencing with the fol-
lowing primers: For 5′-atggtcctgctggagttc-3′; Rev 5′-
tacaaatgtggtatggctg-3′. The progerin construct with lamin A
lacking 50 amino acids (pEGFP-lamin A Δ50) was donated by
Professor Tom Misteli (Addgene plasmid #17653) (Scaffidi
and Misteli 2005).
Cell culture
HEK 293 cells were cultured in Dulbecco’s modified Eagle
medium with high glucose (DMEM 4.5 g/l glucose, Lonza).
The HeLa and NHDF cells were cultured in minimum essen-
tial medium alpha (MEMα, Lonza). All media were supple-
mented with 10 % fetal bovine serum (Sigma), GlutaMAX
supplement (Gibco), antibiotics, and antimycotics (Gibco).
The HEK 293 and HeLa cell lines were purchased from the
Cell Line Collection of the Polish Academy of Sciences,
Institute of Immunology and Experimental Therapy in
Wroclaw. The NHDF cell line was purchased from Lonza.
Cell transfection
HEK 293, HeLa, and NHDF cells were plated on a 24-well
plate 24 h before transfection. For western blot analysis, cells
were transfected using Turbofect Reagent (Thermo Scientific)
according to the manufacturer’s instructions. For other pur-
poses, HEK 293 cells were transfected via electroporation
with a Lonza CLB-Transfection Device according to the man-
ufacturer’s instructions. For immunofluorescence analysis, the
cells were seeded on glass coverslips after electroporation.
Fig. 1 A scheme of lamins A and C indicating the location of the analyzed mutations within their domains and position of epitopes recognized by anti
lamin A/C antibodies used in this study (Machowska et al. 2015)
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Transfection efficiency was routinely ∼90 % for HEK 293,
∼50 % for HeLa, and ∼20 % for NHDF.
The plasmid pEGFP-C1 was used with the following
cDNAs: EGFP, EGFP-lamin A, and EGFP-lamin A Δ50
Table 1 Clinical characterization





Initial symptoms: Achilles tendon and elbow contractures
Clinical presentation: Scapular wasting; contractures of
elbows and ankles; rigidity of the spine; weakness of
proximal and distal muscles
Cardiac arrhythmia: Yes





Initial symptoms: Elbow contractures (from age of 11).
Clinical presentation: Atrophy of arms and calves;
contractures of elbows and ankles; rigidity of the spine
Cardiac arrhythmia: AVB 1/2/3, AF, VT, VF; pacemaker
(aged 28); died at 29 due to decompensated cardiac










Initial symptoms: Elbow, knee, and ankle contractures
(from age of 9).
Clinical presentation: Requires wheelchair; generalized
muscle atrophy; contractures of arms, elbows, knees
and ankles; rigidity of the spine
Cardiac arrhythmia: AVB 1/2/3, PAF, VT, VF; pacemaker
(aged 25); cardiac insufficiency NYHA 2/3; episodes of









EDMD2 phenotype + mild polyneuropathy (familial)
Initial symptoms: Proximal muscle weakness; slim and less
agile than peers (from age of 10)
Clinical presentation: Atrophy of arms, thighs, and calf
muscles; weakness of proximal muscles; rigidity of the
spine; slight elbow, knee and ankle contractures;
decreased superficial sensation in distal parts of lower
limbs







Initial symptoms: Elbow and ankle contractures (aged 6),
rigidity of the spine (aged 7).
Clinical presentation: Requires wheelchair; generalized
muscle atrophy; contractures of arms, elbows, wrists














Initial symptoms: Postnatal growth delay (aged 3 to 6
months)
Clinical presentation: Senile appearance; thin, wrinkled
skin with discolorations and scleroderma-like lesions;
hair loss; gray hair; short stature; osteolysis; dysplasia
of clavicles; coxa valga; cataract; myocardial infarction
or cerebral stroke due to early atherosclerosis
Ultrastructural abnormalities: Nuclear blebbing; thickening
of the lamina; peripheral distribution of heterochromatin




Mutations L263P, E358K, and D446Vwere identified in Polish patients. Positions of the mutations are marked on
lamin A diagram (Fig. 1)
SVT supraventricular tachycardia, VT ventricular tachycardia, VF ventricular fibrillation, SVEB supraventricular
ectopic beats, AVB atrioventricular block, AF atrial fibrillation, PAF paroxysmal atrial fibrillation
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(progerin); and the following EGFP-lamin A mutants: H222P,
L263P, E358K, and D446V. Four hours after transfection with
Turbofect or 18 h after electroporation, the medium was re-
placed with fresh complete medium. Cells were monitored
using an Axiovert 40 CFL fluorescence microscope. After
an appropriate time, the cells were fixed for immunofluores-
cence experiments or collected by trypsinization for western
blot experiments.
Selection of stable transgenic cell lines
After HEK 293 transfection, single cells were transferred to
fresh wells. Clones were verified for proper lamin A localiza-
tion using fluorescent microscopy. For EGFP, EGFP-lamin A,
and the least toxic mutants Δ50 and D446V sublines were
established and cultivated with antibiotic G418 (Sigma) for
over 1 month before analysis.
Electrophoresis and western blot analysis
Whole cell extracts were lysed in Laemmli buffer, separated
via SDS-PAGE (usually with 10 % gels), transferred to nitro-
cellulose membranes, and blocked in 5 % non-fat milk in PBS
for 1 h. Primary antibodies were applied overnight in 4 °C,
while secondary antibodies conjugated with horseradish per-
oxidase (HRP) were applied for 1 h at room temperature.
Proteins were visualized using ECL substrate (BioRad). The
primary antibodies were as follows: mouse anti-human lamin
A/C (Jol2, 1:500), mouse anti-human lamin A (1:1000,
Millipore), mouse anti-humanβ-tubulin (1:3000, Sigma), rab-
bit anti-human emerin prepared in our lab against an N-
terminal fragment of human emerin (1:1000) (Rzepecki
et al. 1998), and rabbit anti-human lamin C (1:500, donated
by Professor C.J. Hutchison), while the secondary antibodies
were donkey anti-mouse HRP (1:3000, Santa Cruz
Biotechnology) and goat anti-rabbit HRP (1:20,000, Jackson
ImmunoResearch).
Indirect immunofluorescence
Cells were plated on glass coverslips, fixed in 4 % parafor-
maldehyde for 20 min, permeabilized with 0.5 % Triton
X-100 in PBS for 5 min in 4 °C and washed with PBS.
Fixed cells were incubated in primary antibody solution over-
night at 4 °C, washed with PBS, and incubated for 1 h with
secondary antibody solution at room temperature and washed
again in PBS and water. Coverslips were mounted on glass
slides using DABCO mounting medium (Fluka) with DAPI.
Staining was visualized on a Zeiss 510 Meta confocal micro-
scope using the 63X objective. Images were processed with
ImageJ and Zeiss ZEN 2008 software for adjusting contrast,
brightness, and size.
All antibodies were diluted in 1 % FBS in PBS. The pri-
mary antibodies used for staining were mouse anti-lamin A/C
(Jol2, 1:20), rabbit anti-emerin (1:30, Proteintech), and rabbit
anti lamin C (C1, 1:20, donated by Professor C.J. Hutchison).
The secondary antibodies were donkey anti-mouse conjugat-
ed with TRITC (1:50), donkey anti-rabbit conjugated with
Cy5 (1:50), and donkey anti-mouse conjugated with
Daylight 649 (1:100), all purchased from Jackson
ImmunoResearch.
Quantitative RT-PCR
Total RNA was isolated from the cultured cells with the
GeneMATRIX Universal RNA Purification Kit (EURx) and
reverse-transcribed using Thermo Scientific Maxima Reverse
Transcriptase (5 μg RNA per reaction). During isolation, the
RNA samples were digested with DNase and then tested for
the presence of genomic DNA using PCR.
The messenger RNA (mRNA) levels of lamins A and C
were measured using specific primers (lamin A: 5′-
taccgacctggtgtggaagg-3′, 5′-gagcgcaggttgtactcagc-3′; lamin
C: 5′-taccgacctggtgtggaagg-3′, 5′-cggcggctaccactcacg-3′).
Real-time PCRwas performed in a 15-μl reaction volume that
included 3 μl of 10× diluted template cDNA and SensiFAST
SYBR No-ROX Kit (Bioline). Runs were performed in trip-
licate. The standard curve was prepared with plasmid contain-
ing cloned amplicons for both lamin A and C, synthesized by
GeneCust. The plasmid dilution range was 7.5 ng to 7.5 fg of
DNA and the amplification for the standard curve was always
performed on the same 96-well plates as the samples and
controls.
The reaction was performed with a CFX 96-Connect Real-
Time PCR Detection System (Bio-Rad) with the following
parameters: 95 °C for 2 min, followed by 40 cycles of dena-
turing at 95 °C for 5 s, annealing at 64 °C for 15 s, and
extension at 72 °C for 8 s. The expression of lamins A and
C was compared to the standard curve with known absolute
copy numbers and calculated against 1 ng of RNA.
Proliferation tests
HEK 293 sublines were seeded on 96-well plates in multiples.
Cells were fixed after 5 days using 10 % TCA for 1 h at 4 °C,
washed with water, and dried. Then, protein was stained with
0.4 % sulphorhodamine B (SRB) in 1 % acetic acid for 30min
at room temperature, washed with 1 % acetic acid, and dried.
Protein-bound dye was dissolved in 150 μl 10 mM Tris base
solution. The OD was measured at 500 nm using a microplate
reader. The test was also validated: the cell lines were seeded




Fluorescence recovery after photobleaching (FRAP) anal-
yses were performed on stable transfected HEK 293 sub-
lines. Cells were cultured on glass coverslips and ana-
lyzed under a ×63 (water immersion) objective in culture
medium using a Zeiss LSM 510 Meta microscope accord-
ing to the manufacturer’s instructions. Optimal conditions
(temperature, humidity, and CO2 levels) were maintained
during analysis. For each subline, FRAP analyses were
performed 4–10 times for up to 2 min per region. For
the calculations, at least three measurements of the best
quality from each set were selected. FRAP analysis soft-
ware (Zeiss LSM 510 software – ZEN 2008) was used for
the experimental setup and data collection (pre-bleach im-
aging, laser pulse, recovery imaging, collection of data,
etc.).
Results
HEK 293 cells have very low lamin A protein expression
levels
We initially decided to use HeLa, NHDF, and HEK 293
cells as the model system in our investigation of the
mechanisms of pathogenesis of novel laminopathy muta-
tions that are as yet uncharacterized. However, we fo-
cused the majority of our detailed experiments on HEK
293 cells, as they are relatively easy to transfect with high
efficiency and have much better tolerance for overexpres-
sion than HeLa cells and fibroblasts (Thomas and Smart
2005). HEK 293 is an embryonic cell line, so it can also
serve as a model for cells that are less differentiated (or
not fully committed). This enabled us to look at the effect
of lamin mutations on the properties of such cells. The
effect of expression of particular lamin A mutants in cells
that are in transition between embryonic and differentiat-
ing states may be important for the understanding of phe-
notype development. HEK 293 cells are a good example
of such cells. All three cell lines express lamins and
emerin, albeit at different levels and localizations
(Fig. 2). In HEK 293 emerin was more cytoplasmic, while
it was mostly in NE in HeLa cells (Fig. 2). In NHDFs,
emerin is mostly in the nucleoplasm and at the NE. This
was observed by immunofluorescence staining (Fig. 2a).
Western blot analysis with comparison to HeLa and NHDF
cells showed that HEK 293 cells contain an undetectable
amount of lamin A protein (Fig. 2c), as could be expected
for less differentiated cells (Constantinescu et al. 2006). The
general rule seems to be that stem cells have no or very low
level of lamin A. However, it was shown that lamin A up-
stream promoter is active during very early development and
then is downregulated (Kubben et al. 2011; Eckersley-Maslin
et al. 2013). The level of lamin C in HEK 293 cells is low but
at a clearly detectable level. Quantitative RT-PCR studies in-
dicated that the amount of lamin A and C transcripts was,
respectively, about 4.7 and 2.3 times lower than in HeLa cells
and 7.6 and 9.9 times lower than in NHDFs (Fig. 2b).
Surprisingly, in HEK 293 cells, the transcript’s level for lamin
A was similar to that for lamin C. This discrepancy between
the similar level of transcripts for lamins A and C and lack of
detectable lamin A protein may suggest that there should be an
additional, posttranscriptional mechanism decreasing the
lamin A level. Since the lamin C protein level corresponds
roughly to the level of its transcript (comparing the ratio
between the protein and its transcript in all three cell lines,
Fig. 2c), we may speculate that the mechanism is specific to
lamin A.
Interestingly, western blot showed that the electrophoretic
mobility of lamin C in HEK 293 cells was significantly higher
than in NHDF (Fig. 2c) and HeLa cells, suggesting posttrans-
lational modifications (proteolysis, dephosphorylation) or al-
ternative splicing of lamin C. The very low level of lamin A
and moderate level of lamin C may confirm the not fully
differentiated status of HEK 293 cells.
Subcellular distribution of lamin A mutants in transient
transfection studies
In order to analyze particular lamin A mutants, we prepared a
set of plasmids encoding fusion protein EGFP and prelamin A
with introduced laminopathy-associated single base mutations
(see Table 1 for the patient phenotype descriptions). A fluo-
rescent tag was chosen mainly due to the technical require-
ments of FRAP measurements, and it was N-terminal to en-
sure proper posttranslational modification of prelamin A
(Coffinier et al. 2010). The mutations were H222P, L263P,
E358K, D446V, and Δ50, with EGFP and wild-type lamin A
constructs used as controls.
We performed transfection of HEK 293 cells and examined
them 24 h (shortest time lap allowing the observation of
EGFP-tagged proteins) and 72 h (longest possible incubation
without cell passaging, due to overgrowth) after transfection.
Subsequently transfections of NHDFs and HeLa cells were
also performed as comparable analyses for differentiated cells
and as a reference point for comparison with other published
studies (Figs. 5 and S1).
Figure 3 shows typical phenotypes of transfected cells ex-
pressing lamin A and its mutants after 24 and 72 h. Each
mutant has its own individual phenotype, which was typically
stronger after 72 h, with the exception of D446V, the pheno-
type of which grew weaker over time. In the case of E358K,
no significant changes in distribution were observed between
24 and 72 h. A similar protein distribution as in HEK 293
cells was also observed in NHDF (Fig. S1A) and HeLa cells
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(data not shown). In general, a low level of expression gen-
erated a typical NE distribution for most mutants, while a
higher level of expression led to accumulation of exogenous
lamin A in nucleoplasmic granules. The only exception was
lamin A Δ50, which accumulates predominantly at the NE
structures, frequently forming large, thick NE membrane
stacks (see also Fig. S2).
Lamin A mutants display different locations
and properties
Figures 3 and 4 show that, depending on the expression level
of a particular protein, different sets of morphological pheno-
types can be observed at high magnification for both wild-
type lamin A and its mutants. At low expression levels,
Fig. 2 A characterization of the HEK 293, NHDF, and HeLa cell lines. a
LaminsA andCwere locatedwithin the NE and nucleoplasm of all of cell
types, but their level was lowest in HEK 293 cells. Emerin localization
differed between cell lines: in NHDF, it is located mostly in the nucleus;
in HEK 293, it is mostly outside the nucleus; and in HeLa, it is mostly
within the nuclear rim. The scale bar is 10 μm long. b A comparison of
the mRNA levels for HEK 293, NHDF, and HeLa cells, measured
separately for spliced forms of lamin A and C, performed using
absolute quantitative RT-PCR. HEK 293 cells had the lowest levels of
lamins A and C, and they were found to be similar. cWestern blot analysis
of protein extracts fromHEK 293 and NHDF cells. The primary antibody
recognizing the epitope common for lamins A and C was used. For
NHDFs, the lamin A and C levels correspond to the mRNA level. For
HEK 293 cells, the level of lamin C corresponded to the mRNA level, but
the level of lamin A is much lower than expected from mRNA
measurement. No signal was detected for HEK 293 lamin A, although
there was ten times more cells per lane than for NHDFs. In addition,
lamin C migrated faster for HEK 293 cells than for NHDFs. HeLa
lamin C migration was the same as for NHDF lamin C (data not shown)
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exogenous lamin A was localized within the NE, usually
forming a mesh that is clearly visible with confocal fluores-
cence microscopy. A high level of wild-type lamin A expres-
sion resulted in the additional appearance of lattice-like
intranuclear aggregates of protein (see also Fig. S2).
The lamin A Δ50 mutant was solely localized in NE, as
expected. A higher level of protein caused stronger enve-
lope deformation (lobulations, invaginations, and mem-
brane stacks) and abnormal NE thickening, but no EGFP
signal was detected in the nucleoplasm (Fig. S2). The lamin
A mutants H222P and L263P tended to aggregate and have
speckle-like distributions, but L263P localized mostly in
the nucleoplasm and H222P mostly within the NE.
Deposits were more likely to be formed by L263P, even in
cells with a relatively low level of exogenous protein. When
protein foci grew bigger, L263P protein recruited endoge-
nous lamin C into the foci structures. This mutant was very
toxic for cells, especially with higher levels of protein.
Most of the high-level mutant-expressing cells did not sur-
vive 72-h incubation after transfection. E358K showed a
dispersed nucleoplasmic location with infrequent nucleo-
plasmic granules at high expression levels. D446V had
the most similar distribution to wild-type lamin A. It
formed a mesh, although with bigger aggregates than
wild-type lamin A. After 72 h, the mutant protein was most-
ly dispersed into small intranuclear granules within the NE
location. This protein also had a relatively low toxicity, so it
was possible to establish a stable cell line encoding lamin A
with this mutation.
Overall, the data showed that stronger phenotypes develop
over time (or when protein expression is higher) and sug-
gested that lamin C levels reduced or even disappeared
completely at the NE and nucleus over time, regardless of
the lamin A variant expressed.
Fig. 3 HEK 293 transfected with
plasmids encoding EGFP, fusion
protein EGFP-prelamin A, and its
mutants, 24 h (left panel) and 72 h
(right panel) posttransfection.
Cells with different levels of
exogenous lamin A proteins were
typically found. There was a
broad spectrum of phenotypes,
depending on both mutation type
and protein level. Arrows
indicates cells with different
levels of exogenous wild-type
lamin A showing that the higher
the lamin A level, the lower the
lamin C level
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Exogenous lamins cause changes in the distribution
but not the expression level of endogenous lamin C
Overexpression of all lamin A proteins (both wild-type and
mutants) results in the reduction or even disappearance of
lamin C in the cell nucleus and NE (as seen with immunoflu-
orescence staining). This effect was stronger 72 h after trans-
fection (Fig. 3). This effect is also clearly shown in Fig. 4.
Distribution analyses performed on representative cells
(Fig. 4) indicated that overexpression of exogenous lamin A
and its mutants resulted in redistribution or disappearance of
lamin C from cell nucleus of transfected cells. This effect was
the lowest in the case of E358K (Figs. 3 and 4). Of the ana-
lyzed mutants, only E358K causes obvious redistribution of
lamin C from the NE to nucleoplasm, even just 24 h after
transfection. However, subsequently, lamin C seems to par-
tially recover after 72 h in some cells (Fig. 3).
To focus on the lamin C signal disappearance in immuno-
fluorescence studies in cells overexpressing the various lamin
A proteins, we conducted western blot experiments. HEK 293
cells were transfected (with over 90 % efficiency) with differ-
ent lamin A constructs and the levels of lamin A, lamin C,
emerin, and exogenous protein were analyzed using western
blots (Fig. 5a). As a control, the same experiments were per-
formed on HeLa cells (Fig. 5b) and NHDFs (Fig. S1B).
It was observed that although the lamin C signal disap-
peared from the NE in the immunofluorescence analysis
(Figs. 3 and 4), there were no visible changes in the overall
level of lamin C protein in the transfected cells (Fig. 5a). This
suggests that lamin C was redistributed, not repressed or fully
degraded. The cells with the highest lamin A expression
showed lamin C distributed within the nucleoplasm or even
cytoplasm (Fig. 4). Seventy-two hours after transfection, some
of the cells with lower level of overexpressed proteins recov-
ered lamin C in NE (Figs. 3 and 4).
Western blot analyses also indicated that there were no
detectable changes in the endogenous lamin A or lamin C
level also in HeLa and NHDF cells expressing exogenous
lamin A proteins (Figs. 5b and S1 B). It must be remembered
that in HEK 293 cells, the endogenous lamin A level is below
the detection level for western blot analyses in comparison
with HeLa and NHDF cells (Fig. 5 and S1B).
In transfected HEK cells expressing high levels of wild-
type lamin A and its mutants Δ50, H222P, and D446V, lamin
C disappears from the NE and cell nucleus 72 h
posttransfection (Figs. 3 and 4). There was no detectable re-
distribution of lamin C into exogenously expressed lamin A
foci inside the nucleus (if present). Mild expression of all the
above mentioned proteins seems to not affect the endogenous
lamin C signal intensity and distribution.
The presence of the most toxic lamin A mutant L263P in
HEK 293 cells induced nucleoplasmic redistribution of en-
dogenous lamin C into areas surrounding the granules of mu-
tant lamin A (Fig. 4). This relocation was observed only when
large nucleoplasmic foci of the mutated protein had been
formed. In fully committed cells such as NHDFs, L263P also
induced redistribution of lamin C into nucleoplasmic foci
(Fig. S1A).
Taking all these results into consideration, our hypothesis
of relocation of endogenous lamin C from the NE as a result of
Fig. 4 HEK 293 transfected with
plasmids encoding EGFP, fusion
protein EGFP-prelamin A, and its
mutants, 72 h posttransfection.
The scale bar is 10 μm long. The
images show representative
nuclei for each mutant and for
comparison, at the same field of
view, there is a control nucleus
(not transfected cell). The far
right column shows signal
intensity as a function of distance
[nm] along drown line for EGFP
(green) and lamin C (red)
channels with transfected cell first
and control cell afterward
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the expression of wild-type lamin A and its mutants is sup-
ported by experimental data from immunofluorescence and
western blot analyses for less differentiated cells (HEK 293)
and fully differentiated cells (HeLa, NHDFs).
Lamin A maintenance in HEK 293 cells
HEK 293 cells have a very low level of endogenous lamin A
compared to HeLa and NHDF cells and compared to their
lamin C level (Figs. 2c and S1B). As mentioned above, lamin
A protein level does not correspond to the transcript level
(Fig. 2) comparing with lamin C protein and both lamins
and corresponding transcripts in HeLa and NHDF cells. We
suggest lamin A specific posttranscriptional mechanism re-
sponsible for this discrepancy.
In HEK 293 cells overexpressing wild-type lamin A,
we observed consistently additional, specific products mi-
grating faster than fusion protein EGFP-lamin A (the
strong protein bands below the band corresponding to
the EGFP-lamin A fusion protein in Fig. 5a). Such prod-
ucts were present also when mutant lamins were
expressed. In HeLa cells and NHDFs, no such products
were detected (Figs. 5b and S1).
In samples from transfected HEK 293 cells, when
overdeveloped, it is possible to detect products migrating
as wild-type lamin A degradation products with cleaved-
off EGFP from expressed fusion protein. Other than lamin
A, EGFP fusion proteins, overexpressed in HEK cells did
not show this effect (data not shown). This is consistent
with our observations from HEK 293 stable cell lines
selected after transfection. During the establishment of
the cell lines overexpressing lamin A variants, only cells
with the lowest level of lamin A survived. Additionally,
some clones showed partial cytoplasmic EGFP-tag local-
ization, identical with EGFP protein alone. This can be a
degradation product formed by cutting fusion protein.
Degradation products were only observed in HEK 293
cells and only for lamin A (and mutants), and only the
lamin A protein level is not proportional to the measured
level of its transcript. Therefore, this indicates efficient
posttranscriptional regulation of the lamin A level in
HEK 293 cells. Proteolysis of lamin A may play a role
in this regulation.
Overexpression of lamin A and mutants does not affect
emerin expression and distribution
We also analyzed the distribution of emerin in transfected
cells since emerin recruitment into the nuclear envelope is
dependent on lamin A. We were interested in detection of
the potential effect of lamin A and mutant overexpression
on emerin expression and distribution using transient
transfection followed by western blot and immunofluores-
cence analyses. Western blot analyses indicated that there
were no detectable changes in the emerin level in HEK
293, HeLa, and NHDF cells expressing exogenous lamin
A proteins (Figs. 5 and S1B). Unfortunately, transient
transfection studies were inconclusive, mostly due to the
high heterogeneity of phenotypes and inconsistency of
lamins’ expression level. Therefore, we used stable HEK
293 cell lines expressing lamin A and mutants for such
analyses (Fig. 6). No changes in distribution of emerin
were observed in stable cell lines expressing lamin A
and mutants in HEK 293 cells.
Lamin A mutants change the proliferation rate of HEK
293 cells
Previously published experimental data indicated that knock-
out (or knockdown) of wild-type lamin A and its mutant Δ50
expression affects differentiated cells by slowing down their
proliferation rate (Cohen et al. 2013; Vidak et al. 2015). In
order to test this effect on a tissue culture model of less-
differentiated cells, we used HEK 293 cells. We selected sub-
lines expressing comparable amounts of exogenous proteins.
Typical phenotype of those cells is presented in Fig. 7a.
HEK 293 sublines stably expressing EGFP and lamin
A variants were analyzed for their proliferation rate in
Fig. 5 Western blot analysis of HEK 293 (a) and HeLa (b) cells,
collected 72 h posttransfection with plasmids encoding EGFP, EGFP-
prelamin A, and its mutants. Transfection efficiency was around 90 %
for HEK 293 cells and around 50 % for HeLa cells. Exogenous lamin A
underwent degradation in HEK 293 cells, but not in HeLa cells. Progerin
detection was impaired due to the epitope not being recognized by the
anti-lamin A antibody
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standard SRB assays (Fig. 7b). As expected, overexpres-
sion of the exogenous proteins slowed down the prolifer-
ation of HEK 293 cells. The expression of a Bneutral^
protein, such as EGFP, slowed down proliferation by
50 % compared to the control cells. Wild-type lamin A
slowed down the proliferation rate by another 10 % com-
paring to EGFP (60 % compared to the control), which is
statistically significant. Lamin A Δ50 expression resulted
in about a 15 % proliferation slowdown compared to the
control, but about a 200 % increase in the proliferation
rate compared to wild-type lamin A. Lamin A D446V had
a slightly higher proliferation rate (about 215 % compared
to wild-type lamin A) than progerin. Proliferation slow-
down compared to the control HEK 293 cell line was only
about 12 %, which was not statistically significant.
These data indicate that lamin mutants affect proliferation
also in less-differentiated cells. However, in contrast to mature
cells (Kudlow et al. 2008; Vidak et al. 2015), Δ50 mutation
has the opposite effect: there is no inhibition of proliferation.
The NE-associated lamin A Δ50 and D446V fractions have
similar mobility to wild-type lamin A
Different mutations affect lamin A properties in different
ways. Since the basic properties of lamin are polymerization,
filament formation, and interaction with integral membrane
proteins and chromatin, the mobility analyses of mutant pro-
tein inside cells may indicate the extent of abnormality of the
mutant. The most characteristic mutant from the point of view
of mobility is lamin A Δ50, since it is permanently
farnesylated and presumably immobilized to the NE mem-
brane (even when not polymerized) due to the lipophilic
farnesyl Banchor.^
For studies of lamin mobility, we used the FRAP technique
with the established cell lines stably expressing comparable
amounts of a given lamin. The mobility of all of the lamins
was analyzed at the NE using EGFP as a control protein with
high mobility (Fig. 7). Figure 7a shows the analyzed cell phe-
notypes and confirms the comparable level of expression of
Fig. 6 The location of
endogenous emerin is not
changed in HEK 293 sublines
expressing EGFP, lamin A,
progerin or lamin A D446 in
comparison to control (not
transfected cells). Scale bar is
10 μm long
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exogenous lamin A. Figure 7c shows the actual mobility data
and detection range (insert).
The analyses revealed that lamin A and all its studied mu-
tants (together with Δ50) showed similar low mobility during
all experiments in the HEK 293 cells. LaminAD446V showed
the highest mobility (up to 10 % higher than lamin A), while
lamin A Δ50 showed the lowest (about 10 % lower than lamin
A). No statistical significance was detected within this trend.
Discussion
Mutations in the LMNA gene are associated with over 15
disease phenotypes, including striated muscle diseases, pe-
ripheral neuropathy, lipodystrophy, bone diseases, and prema-
ture ageing syndromes with multisystemic pathology
(Schreiber and Kennedy 2013). Although disease-causing
mutations are located in known hot spots in some
laminopathies (e.g. HGPS, mandibulacral dysplasia, familial
partial lipodystrophy, and restrictive dermopathy), there are no
clear genotype–phenotype correlations in other conditions
(mainly those affecting skeletal and cardiac muscles). We
might suspect that the complex spectrum of those diseases is
associated with a disturbed development that influences par-
ticular tissues depending on the mutation type.
We investigated lamin A mutants introduced into three cell
lines: HEK 293, HeLa, and NHDF. Our focus was on HEK
293 due to its interesting properties and the poor state of
knowledge about lamins in less-differentiated cells. This line
was previously used for analysis of lamin A mutants, but only
for rough screening (Tan et al. 2015) or as an additional con-
trol for fibroblasts studies (Capanni et al. 2009; Capanni et al.
2012). The phenotypes of the other cell lines transfected with
lamin A mutants were similar, but less pronounced.
Fig. 7 Analysis of HEK 293 sublines stably expressing EGFP alone and
lamin A and its mutants D446V and Δ50 (progerin). a Confocal
microscopy shows that all lamin A variants localize within the NE.
Protein aggregates are much smaller than during transient transfection
studies due to the lower level of exogenous proteins; however, some
foci are still clearly visible. Progerin causes NE lobulations and the
strongest deformation of the nuclear shape. b A proliferation
comparison of the sublines was performed with the SRB assay 5 days
after seeding. EGFP and lamin A expression significantly inhibits
proliferation relative to the control, suggesting that the general effect of
introducing exogenous protein may have a major role in this process.
D446V and Δ50 abolished this effect, so they were able to increase the
proliferation rate in embryonic cells. n/s not significant. c A comparison
of protein mobility was performed using FRAP analysis. EGFP alone is
very mobile: it immediately refilled the bleached area. By contrast, wild-
type lamin A, progerin, and D446V proteins did not replace bleached
lamin A. It shows that mutations did not significantly change protein
mobility within the NE. Measurements were performed for up to 120
seconds. The insert nucleus picture shows the typical bleached area with
a red circle (the merge of the EGFP and transmission light channels)
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HEK 293 is an immortalized embryonic cell line, with high
transfection efficiency and a good tolerance of exogenous
proteins. We showed that it has a very low level of lamin A
and a moderate level of lamin C. Low lamin A levels confirm
HEK 293 as a good model for less-differentiated cell lines
(Constantinescu et al. 2006). In addition, its lamin C migrates
faster in western blot than that of NHDF or HeLa cells, which
suggests different posttranslational modifications or an alter-
native spliced form that was not detected previously. Although
the mRNA level for lamin A is similar to that for lamin C, the
main spliced protein form in the cell is lamin C. This can result
from mRNA translation inhibition or proteolytic degradation
or autophagy, or both (Cenni et al. 2011; Dou et al. 2015).
Since exogenously expressed lamin can undergo autophagy-
related proteolysis in HEK 293 cells (Cenni et al. 2011), and
proteolytic degradation may be induced among other mecha-
nisms by Akt1 phosphorylation of lamin A on serine 404
(Cenni et al. 2008; Bertacchini et al. 2013), it is plausible that
autophagy-related proteolysis may be a possible mechanism.
Similar feature of unpredicted level of expression was ob-
served in the cause of lamin A nonsense mutant
(pArg321Ter) causing dilated cardiomyopathy (Al-Saaidi
et al. 2013).
HEK 293 cells are known to have the molecular properties
of neural cells (Shaw 2002), and lamin A is known to be
specifically downregulated within neural cells by miR-9
(Jung et al. 2012). However, miR-9 seems to be absent in
HEK 293 cells (Giusti et al. 2014) but the expression of the
homologous sequence of miR-79 has never been tested. In
addition, we observed, beside normal proteins, faster migrat-
ing form of lamin A andmutants in western blots. This implies
that in HEK 293 cells may exist posttranscriptional mecha-
nism regulating lamin A level based on another mechanism
than in neuronal cells. However, the molecular background of
this mechanism needs to be resolved.
To test the effect of laminopathy-associated mutations at
the cellular level, we introduced a set of lamin A mutants to
less-differentiated and differentiated model cell lines. We fo-
cused on the stage before differentiation and investigated the
impact of disturbing the lamin A balance and the effect of the
particular mutations connected with EDMD2 and HGPS on
the cell phenotype and proliferation. We chose novel muta-
tions, L263P and D446V, which had been found in Polish
patients, and we provided their molecular characterization
for the first time. As a comparison, we used the better-
known mutations E358K, H222P, and Δ50. Patients bearing
the chosen mutations were deeply characterized clinically to
allow for a better understanding of the relationship between
genotype and phenotype. The phenotypes of EDMD2 patients
were of comparable severity (Table 1), but the chosen muta-
tions provided a wide spectrum of nuclear phenotypes that
were significantly enhanced in HEK 293 cells compared to
the differentiated cells (Figs 3, 4 and S1). Themutants differ in
their tendency to aggregation, cellular toxicity, localization
(NE vs. nucleoplasm) and impact on lamin C (Figs. 3 and
4). L263P has the greatest tendency to form foci, even at
low expression levels. H222P also forms foci but less effi-
ciently. E358K is translocated to the nucleoplasm and aggre-
gates only at the highest expression levels. D446V forms
lattice-like structure similar to those of wild-type lamin A in
HEK 293 cells.
The different properties of these proteins may result from
their location within various domains. H222P and L263P are
located within or close to linkers in the coil 2A domain. They
introduce the proline residue known as protein secondary struc-
ture disruptor. Those mutations are most likely to affect lamin
dimerization, and the obtained results suggest that they enhance
this process. E358K is located in part of the coil 2B domain that
is highly conserved among vertebrates and invertebrates
(Strelkov et al. 2004). It changes the amino acid residue polar-
ity as negatively charged glutamic acid is replaced by positively
charged lysine. This mutation can affect filament assembly but
not dimerization (Strelkov et al. 2004). D446V is localized
within the Ig fold and substitutes an acidic residue into a neutral
one in an evolutionally conserved region of negatively charged
amino acid residues (442VEEVDEEG). This amino acid was
found to be exposed within the Ig fold, so it was predicted to
influence DNA, RNA, and/or protein binding rather than affect
protein structure (Dittmer et al. 2014; Scharner et al. 2014) or
polymerization (Machowska et al. 2015). This is supported by
our studies: D446V did not visibly change lamin A properties
or the cellular phenotype.
The chosen set of LMNA gene mutations can be useful for
further studies, because they probably cause EDMD2 through
various mechanisms. Different aggregates formed by lamin A
mutants can lead to different patterns of redistributed
interacting proteins, among other effects–e.g., E358K may
redistribute interacting proteins into nucleoplasm as it does
for lamin C (Figs. 3 and 4) while the most toxic L263P may
recruit interacting proteins (also a fraction of lamin C) into
intranuclear foci (Fig. 4).
The regulation of A-type lamins during development and
in particular tissues seems to be a very complex process. At
least two major signaling pathways essential in development
may be affected by the expression of lamin A/C. These are
pRB pathway and Wnt/β-catenin pathway while retinoic acid
signaling pathway, also essential for development, contributes
to lamin A/C expression and is also affected by lamin A (for
review, see Dubinska-Magiera et al. 2013). Lamin A is
expressed in early development, then lost and expressed again
during differentiation. LMNA promoter is activated in some
tissues, e.g., the heart, liver, and somites, on day 11 of mouse
embryonic development (Kubben et al. 2011). On the other
hand, A-type lamins in the heart, liver, and other organs were
undetectable using immunodetection after birth (Rober et al.
1989). This suggests an additional mechanism that inhibits A-
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type lamin expression. More recent studies revealed that low-
level A-type lamins are detectable in embryonic stem cells and
mouse blastocysts (Eckersley-Maslin et al. 2013). In addition
to their promoter activity, A-type lamin expression is known
to be regulated through alternative splicing or mRNA degra-
dation. Lamins A and C are present at various levels in differ-
ent tissues. For example, lamin A is specifically downregulat-
ed by miR-9 in brain (Jung et al. 2012).
Lamin C distribution was revealed to be dependent on lamin
A level, localization, and mutations (Fig. 4). It was previously
shown that lamin C and emerin targeting to the NE depends on
lamin A (Sullivan 1999; Vaughan et al. 2001). Two LMNA
spliced forms (lamin C and lamin A Δ50) even seem to have
opposite functions in the context of energy metabolism (Lopez-
Mejia et al. 2014). It is known that lamins A and C have different
expression patterns and binding properties, and it was proposed
that the imbalance between those spliced forms can result in
pathogenesis (Al-Saaidi and Bross 2015). As observed in our
study, lamin C redistribution may suggest the mechanism of this
disturbance. In addition, emerin localization outside the nucleus
(Fig. 2) can be the result of very low level of lamin A in HEK
293 cells. On the other hand, in sublines stably expressing exog-
enous lamin A no redistribution of emerin was observed (Fig. 6)
which may suggest that interaction with lamin A is not an only
mechanism responsible for emerin location (Salpingidou et al.
2007; Salpingidou et al. 2008; for review, see Berk et al. 2013).
In general, via immunofluorescence, we observed that the higher
the level of exogenous lamin A, the lower the level of endoge-
nous laminC, especiallywithin theNE (Figs. 3 and 4). However,
western blot analysis showed that the level of endogenous lamin
C is stable (Fig. 5, performed on cells with at least 90 % trans-
fection efficiency). This suggests that lamin C is not downregu-
lated nor degradated, but dispersed within the cell. Lamin C
redistribution was previously shown in X-EDMD patient cells
(Markiewicz et al. 2002). Our observations of different lamin A
mutants allow us to propose that the mechanism of lamin C
translocation is partially based on binding by lamin A. When
E358K, which localizes predominantly in nucleoplasm, is
overexpressed, lamin C also localizes mostly there, while in
cases of Δ50 overexpression (permanently bonded with the NE
and localized there), laminC is localized onlywithinNE (Fig. 4).
In order to investigate the impact of novel mutations on cell
proliferation and protein mobility, we established HEK 293
sublines that stably express lamin A and its mutants Δ50 and
D446V. L263P mutations were found to be extremely toxic,
and it was not possible to establish a subline expressing this
mutant. Lamin A mutations did not change protein mobility
significantly within the nuclear rim, which was not surprising,
because lamin mutants rarely change it (Broers et al. 2005).
Proliferation tests revealed that lamin A overexpression
leads to diminishing propagation of cells, as was previously
reported for immortalized fibroblasts (Vidak et al. 2015) or
COS-7 cells (Ivorra et al. 2006). Surprisingly, the presence
of Δ50 or D446Vin cells reversed the decrease in proliferation
(Fig. 7). This suggests that HEK 293 cells may have a differ-
ent (or abolished) mechanism of cell division control. To in-
vestigate this phenomenon, we performed cell cycle analysis,
but it did not show any difference in the cell cycle phases
between the sublines (data not shown). Cell cycle arrest was
previously reported in cells obtained from LMNA−/− mice
(Pekovic et al. 2007; Cohen et al. 2013), but we did not ob-
serve it here with lamin A mutants present.
It was also described that lamin A Δ50 expression is corre-
lated with a diminishing proliferation rate in aged patient-
derived or immortalized fibroblasts (Scaffidi and Misteli
2006; Kudlow et al. 2008). In addition, various lamin A mu-
tations decrease the colony-forming capacity of mesenchymal
stem cells (Malashicheva et al. 2015).
The adverse effect observed for HEK 293 cells may result
from changed pathways due to immortalization with adenovi-
rus proteins E1A and E1B (Lin et al. 2014). E1B can inhibit
the p53 pathway and E1A can sequestrate to Rb, releasing and
activating E2F transcription factors (Chakraborty and Tansey
2009). It was shown that in fibroblasts, Δ50-dependent
diminishing of proliferation can rely on p53 (Kudlow et al.
2008) and Rb localization and activity depend on the presence
of lamin A (Pekovic et al. 2007). Impairment of these path-
waysmay result in a different effect of lamin A and its mutants
on the proliferation rate in HEK 293 cells. It should be pointed
out that the presence of the lamin A mutants D446Vor Δ50
cause twofold faster cell propagation compared with Bneutral^
protein EGFP overexpression (Fig. 7). This suggests that both
Δ50 and D446V may stimulate proliferation.
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